The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects
Open accessAbstract
RationaleThis dose-effect study extends previous observations showing that psilocybin can occasion mystical-type experiences having persisting positive effects on attitudes, mood, and behavior.ObjectivesThis double-blind study evaluated psilocybin (0, 5, 10, 20, 30 mg/70 kg, p.o.) administered under supportive conditions.MethodsParticipants were 18 adults (17 hallucinogen-naïve). Five 8-h sessions were conducted individually for each participant at 1-month intervals. Participants were randomized to receive the four active doses in either ascending or descending order (nine participants each). Placebo was scheduled quasi-randomly. During sessions, volunteers used eyeshades and were instructed to direct their attention inward. Volunteers completed questionnaires assessing effects immediately after and 1 month after each session, and at 14 months follow-up.ResultsPsilocybin produced acute perceptual and subjective effects including, at 20 and/or 30 mg/70 kg, extreme anxiety/fear (39% of volunteers) and/or mystical-type experience (72% of volunteers). One month after sessions at the two highest doses, volunteers rated the psilocybin experience as having substantial personal and spiritual significance, and attributed to the experience sustained positive changes in attitudes, mood, and behavior, with the ascending dose sequence showing greater positive effects. At 14 months, ratings were undiminished and were consistent with changes rated by community observers. Both the acute and persisting effects of psilocybin were generally a monotonically increasing function of dose, with the lowest dose showing significant effects.ConclusionsUnder supportive conditions, 20 and 30 mg/70 kg psilocybin occasioned mystical-type experiences having persisting positive effects on attitudes, mood, and behavior. Implications for therapeutic trials are discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“High MEQ-30 scores have also been found to predict changes in personality-trait openness (MacLean et al., 2012) and positive changes in attitudes, mood, and behavior (Griffiths et al., 2011).”
From Assessment of the acute subjective psychedelic experience: A review of patient-reported outcome measures in clinical research on classical psychedelics (2024) · cites this paper as Griffiths et al., 2011
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“it has been repeatedly found that psychedelic-induced mystical-type experiences and ego dissolution, the latter a phenomenon characterized by the reduction in self-referential awareness, disruption self-world boundaries, and increased feelings of unity with one’s surroundings (55), correlates with long-term (positive) outcomes (23, 52–54, 56–58).”
From Decreases in State and Trait Anxiety Post-psilocybin: A Naturalistic, Observational Study Among Retreat Attendees (2022) · cites this paper as [57]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Compared to the active placebo group, both groups which received a high dose of psilocybin reported significantly higher enhancements in mood, well-being and life satisfaction, as assessed by the Persisting Effects Questionnaire (87).”
From Examining the Potential Synergistic Effects Between Mindfulness Training and Psychedelic-Assisted Therapy (2021) · cites this paper as [87]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“phase I and II studies suggest a dose-dependent effect on the quality of the psychedelic experience [54, 76]”
The cited source says what the claim attributes to it.
In the citing paper
“5 mg of psilocybin was shown to induce subjective changes significantly greater than those of an inert placebo; [76]”
The cited source says what the claim attributes to it.
In the citing paper
“with high mystical experience scores associated with 30 mg/70 kg of psilocybin [76]”
The cited source says what the claim attributes to it.
In the citing paper
“Undergoing a mystical-type experience during the acute effects of a psychedelic has been associated with healthy volunteers reporting an improvement in their wellbeing [51, 52], and reductions in depression symptoms in participants with life-threatening cancer [19, 20].”
From The psychological processes of classic psychedelics in the treatment of depression: a systematic review protocol (2022) · cites this paper as [51]
The cited source says what the claim attributes to it.
In the citing paper
“Mindfulness meditation and mindfulness-based interventions can augment positive affect in healthy and clinical populations acutely and long-term (10, 88) and a similar mood-enhancing potential has been demonstrated for psychedelics such as psilocybin (29, 38, 60, 83, 87).”
From Examining the Potential Synergistic Effects Between Mindfulness Training and Psychedelic-Assisted Therapy (2021) · cites this paper as [87]
The cited source says what the claim attributes to it.
In the citing paper
“Controlled studies where subjects achieved mystical experiences under the effects of psilocybin showed personal long-term benefits (Griffiths et al., 2008; Griffiths et al., 2011).”
From Psychological variables implied in the therapeutic effect of ayahuasca: A contextual approach (2018) · cites this paper as Griffiths et al., 2011
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Importantly, previous studies utilising psychedelic-administration outside of a mindfulness-enhancing context have failed to show such positive trait changes (83, 87, 133), with the exception of trait openness (74, 134).”
From Examining the Potential Synergistic Effects Between Mindfulness Training and Psychedelic-Assisted Therapy (2021) · cites this paper as [87]
Experimental — accuracy not yet measuredIn the citing paper
“and a dose-response study in healthy volunteers suggested that optimum psilocybin dosing for eliciting a well-tolerated yet transcendent experience may be between 0·29 mg/kg and 0·43 mg/kg [32].”
From Psilocybin-assisted group therapy for demoralized older long-term AIDS survivor men: an open-label safety and feasibility pilot study. (2020) · cites this paper as [32]
In the citing paper
“Self-reported increases in interpersonal closeness and positive/altruistic social effects were reported 1, 2, 6, and 14 months after one and two administrations of psilocybin (89–92).”
From Modulation of Social Cognition via Hallucinogens and “Entactogens” (2019) · cites this paper as [91]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Griffiths, R. R., Richards, W. A., McCann, U., & Jesse, R. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0457-5 · Cited by 1,684 · cited 23×
“The questionnaire included three additional questions (see Griffiths et al. 2006 for more specific wording): (1) How personally meaningful was the experience?”
BackgroundMethodResultInfluentialSelf-citationThe Psychology of Religion: An Empirical Approach
Donahue, M. J., Hood, R. W., Spilka, B., Hunsberger, B. E., & Gorsuch, R. L. (1998) · Journal for the Scientific Study of Religion · doi:10.2307/1388044 · Cited by 1,339
Nichols, D. E. (2004) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2003.11.002 · Cited by 1,211
Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer
Grob, C. S., Danforth, A. L., Chopra, G. S., Hagerty, M., McKay, C. R., Halberstadt, A. L., & Greer, G. R. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.116 · Cited by 1,206
Human hallucinogen research: guidelines for safety
Johnson, M., Richards, W., & Griffiths, R. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881108093587 · Cited by 1,203
Self-citationMartin, W. R., Sloan, J. W., SAPIRA, J. D., & Jasinski, D. R. (1971) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1971122part1245 · Cited by 945
The Psychology of Religion: An Empirical Approach
Hall, C. M., Spilka, B., Hood, R. W., & Gorsuch, R. L. (1986) · Journal for the Scientific Study of Religion · doi:10.2307/1386305 · Cited by 943
Griffiths, R., Richards, W., Johnson, M., McCann, U., & Jesse, R. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881108094300 · Cited by 905
Self-citationEvidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents
Glennon, R. A., Titeler, M., & MCKENNEY, J. D. J. (1984) · Life Sciences · doi:10.1016/0024-3205(84)90436-3 · Cited by 635
The Psychology of Religion: An Empirical Approach
Hunsberger, B. E., Spilka, B., Hood, R. W., & Gorsuch, R. L. (1986) · Review of Religious Research · doi:10.2307/3511875 · Cited by 626
Research works printed but not linked: 5
- Metzner R (2004) Teonanacatl: sacred mushroom of visions. Four Tree, El Verano
- Metzner R, Litwin G, Weil G (1965) The relation of expectation and mood to psilocybin reactions: a questionnaire study. Psychedelic Rev 5:3–39
- Pahnke W (1963) Drugs and mysticism: an analysis of the relationship between psychedelic drugs and the mystical consciousness. Thesis presented to the President and Fellows of Harvard University for the Ph.D. in Religion and Society
- Stolaroff MJ (1997) The secret chief revealed. Multidisciplinary Association for Psychedelic Studies, Sarasota
- VandeCreek L (1999) The death transcendence scale. In: Hill PC, Hood RW Jr (eds) Measures of religiosity. Religious Education Press, Birmingham, pp 442–445
Cited by
Sorted by citations
Items 801–900 of 979
Psilocybin as an Inducer of Ego Death and Similar Experiences of Religious Provenance
Stebelska, K., & Łabuz, K. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-800212-4.00082-0
Psychedelic therapy from an existential psychological viewpoint : a theoretical analysis
Berg, S. H. (2016) · NORA - Norwegian Open Research Archives
The Relationship between Anxiety Vulnerability Factors, Psychedelic Drug Use and Trait Anxiety
Ursa, F. (2016) · Lund University Publications Student Papers (Lund University)
Doświadczenie psychodeliczne jako doświadczenie poznawcze
Nowak, S. (2015) · Hybris · doi:10.18778/1689-4286.30.08
Peng, L. (2014) · Journal of International Crisis and Risk Communication Research
Psychedelic psychotherapy : existential and neuroscience perspectives on the therapeutic journey
Seelig, A. W. (2017) · Smith ScholarWorks (Smith College)
Shaw, L. (2018) · UVic’s Research and Learning Repository (University of Victoria)
Psykedeelien katalysoima mystinen kokemus kokemuskerronnan näkökulmasta
Pieskä, T. (2018) · Uskonnontutkija - Religionsforskaren · doi:10.24291/uskonnontutkija.v7i2.77405
Brabant, O. (2018) · Jyväskylä University Digital Archive (University of Jyväskylä)
Il Default Mode Network: la scoperta, la struttura, le proposte teoriche
Mancuso, L. (2019) · RICERCHE DI PSICOLOGIA · doi:10.3280/rip2019-002001
Temporal Lobe Epilepsy, Dostoyevsky and Irrational Significance
Coles, A. J. (2019) · Cambridge University Press eBooks · doi:10.1017/9781316014165.010
Embodied Cognition and the Neurology of Religion
Brown, W. S. (2019) · Cambridge University Press eBooks · doi:10.1017/9781316014165.005
Near-Death and Out-of-Body Experiences
Marsh, M. N. (2019) · Cambridge University Press eBooks · doi:10.1017/9781316014165.020
Chappell, S. G. (2019) · Cambridge University Press eBooks · doi:10.1017/9781316014165.008
Examining the Continuum of Life to Determine Death
Buchman, A. S. (2019) · Cambridge University Press eBooks · doi:10.1017/9781316014165.019
The Nature of Healing in the Psychedelic Experience
Criddle, A. (2020) · PhilPapers (PhilPapers Foundation)
Good Friday Experiment (Aka Marsh Chapel Experiment)
Kime, K. G. (2020) · Springer eBooks · doi:10.1007/978-3-030-24348-7_200209
Nilsson, M. (2020) · Lund University Publications Student Papers (Lund University)
Mitina, O. V., Мирсаидов, М. М., Молчанова, Н. П., & Tutrin, A. (2020) · PsyArXiv (OSF Preprints) · doi:10.31234/osf.io/b7mnz
The Effect of Psilocybin on Personality
LaBua, R. (2021) · CUNY Academic Works (City University of New York)
Cosas del dominio (Lección de Paolo Grossi).
Salvador, B. C. (1992) · Dialnet (Universidad de la Rioja)
ルポ 昼休みを生かしてリフレッシュ--東京急行電鉄(株)車両部長津田検車区 (作業の合間でリフレッシュ--休憩時間の過ごし方のヒント )
労働衛生編集部 (1995) · 労働衛生
Coles, A. J., & Collicutt, J. (2019) · Cambridge University Press eBooks · doi:10.1017/9781316014165.001
Coles, A. J., & Collicutt, J. (2019) · Cambridge University Press eBooks · doi:10.1017/9781316014165.022
(2019) · Cambridge University Press eBooks · doi:10.1017/9781316014165.021
(2014) · CRC Press eBooks · doi:10.1201/b17423-69
von Heyden, M., & Jungaberle, H. (2017) · Springer eBooks · doi:10.1007/978-3-642-55214-4_43-1
(2012) · Le Journal des psychologues · doi:10.3917/jdp.303.0050
The good, the bad, and the intoxicated
Mason, N. L. (2021) · Research Publications (Maastricht University) · doi:10.26481/dis.20210608nm
Hollander, E., & Uzunova, G. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.735236753.793581300
Nondual awareness: consciousness as such as non-representational reflexivityPreprint
Josipovic, Z. (2021) · MindRxiv (OSF Preprints) · doi:10.31231/osf.io/umfyg
Faculty Opinions recommendation of Psychedelics promote structural and functional neural plasticity.
Chapman, E. R., & Vevea, J. (2018) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.733441066.793547403
Bonson, K. R. (2020) · Wiley eBooks · doi:10.1002/9780470015902.a0029200
Forstmann, M., & Sagioglou, C. (2021) · PsyArXiv (OSF Preprints) · doi:10.31234/osf.io/2489x
Marsh, M. N. (2021) · New approaches to the scientific study of religion · doi:10.1007/978-3-030-67326-0_10
From Ego to Death: Validation of the Ego-Dissolution Scale (EDS)
Senanayake, R. (2022) · Open Access Victoria University of Wellington | Te Herenga Waka (Figshare) · doi:10.26686/wgtn.20380158
Et psykoanalytisk og et postmoderne perspektiv på selv/egoopløsning i en psykedelisk kontekstPreprint
Andersen, S. (2023) · PsyArXiv (OSF Preprints) · doi:10.31234/osf.io/f26ce
Thompson, C. W., & Husain, M. I. (2023) · Oxford University Press eBooks · doi:10.1093/med/9780192863607.003.0001
Music's essential role during psychedelic therapy
Kahn, A. J., & Ierardi, F. (2021) · iDEA - Drexel University Institutional Repository · doi:10.17918/00001535
Tetem, J., Fischmann, T., & Möller, T. J. (2023) · PsyArXiv (OSF Preprints) · doi:10.31234/osf.io/ztyxh
use of psilocybin in the treatment of psychiatric disorders – review
Woźniak, J., BOGACZ, R., Gaik, M., Ewa, U. R. A. M., MAGDA, I., Womperski, K., & OSUCH, M. (2023) · Journal of Education Health and Sport · doi:10.12775/jehs.2023.43.01.009
Lyon, A. (2023) · Oxford University Press eBooks · doi:10.1093/oso/9780198843757.003.0010
Lyon, A. (2023) · Oxford University Press eBooks · doi:10.1093/oso/9780198843757.003.0011
Lyon, A. (2023) · Oxford University Press eBooks · doi:10.1093/oso/9780198843757.003.0008
Lyon, A. (2023) · Oxford University Press eBooks · doi:10.1093/oso/9780198843757.003.0006
Lyon, A. (2023) · Oxford University Press eBooks · doi:10.1093/oso/9780198843757.003.0012
(2023) · Oxford University Press eBooks · doi:10.1093/oso/9780198843757.002.0006
Lyon, A. (2023) · Oxford University Press eBooks · doi:10.1093/oso/9780198843757.003.0007
(2023) · Oxford University Press eBooks · doi:10.1093/oso/9780198843757.002.0003
Lyon, A. (2023) · Oxford University Press eBooks · doi:10.1093/oso/9780198843757.003.0004
What Is Psychedelic Experience?
Lyon, A. (2023) · Oxford University Press eBooks · doi:10.1093/oso/9780198843757.003.0002
(2023) · Oxford University Press eBooks · doi:10.1093/oso/9780198843757.002.0005
Lyon, A. (2023) · Oxford University Press eBooks · doi:10.1093/oso/9780198843757.003.0003
7450 Summit Cir, D., & Alnaher, S. (2023) · Journal of Sociology Psychology & Religious Studies · doi:10.53819/81018102t4237
Farmakológiai biopolitikák (1. rész) : A lélek vegyészete
Básthy, Á., & Lengyel, Z. (2023) · Replika · doi:10.32564/129.1
Breeksema, J. J. (2024) · University of Groningen research database (University of Groningen / Centre for Information Technology) · doi:10.33612/diss.912040905
Hunt, H. T. (2024) · International Journal of Transpersonal Studies · doi:10.24972/ijts.2023.42.2.1
Introduction to the EMBARK Approach
Brennan, B., & Belser, A. (2024) · Oxford University Press eBooks · doi:10.1093/9780197762622.003.0003
Brennan, B., & Belser, A. (2024) · Oxford University Press eBooks · doi:10.1093/9780197762622.003.0006
Bringing It Home and Carrying It Forward
Brennan, B., & Belser, A. (2024) · Oxford University Press eBooks · doi:10.1093/9780197762622.003.0009
Considerations Prior to Meeting With a Participant
Brennan, B., & Belser, A. (2024) · Oxford University Press eBooks · doi:10.1093/9780197762622.003.0005
INTRODUCTION: A New Approach for the Whole Person
Brennan, B., & Belser, A. (2024) · Oxford University Press eBooks · doi:10.1093/9780197762622.003.0001
Choosing Suggested Integration Goals
Brennan, B., & Belser, A. (2024) · Oxford University Press eBooks · doi:10.1093/9780197762622.005.0004
Working Within the EMBARK Domains Cheat Sheet
Brennan, B., & Belser, A. (2024) · Oxford University Press eBooks · doi:10.1093/9780197762622.005.0003
Brennan, B., & Belser, A. (2024) · Oxford University Press eBooks · doi:10.1093/9780197762622.003.0007
Brennan, B., & Belser, A. (2024) · Oxford University Press eBooks · doi:10.1093/9780197762622.005.0002
An Overview of Psychedelic-Assisted Therapy
Brennan, B., & Belser, A. (2024) · Oxford University Press eBooks · doi:10.1093/9780197762622.003.0002
Personal Care for the Therapist
Brennan, B., & Belser, A. (2024) · Oxford University Press eBooks · doi:10.1093/9780197762622.005.0001
Brennan, B., & Belser, A. (2024) · Oxford University Press eBooks · doi:10.1093/9780197762622.003.0008
Brennan, B., & Belser, A. (2024) · Oxford University Press eBooks · doi:10.1093/9780197762622.002.0004
EMBARK Mechanisms of Change in the Treatment of Depression
Brennan, B., & Belser, A. (2024) · Oxford University Press eBooks · doi:10.1093/9780197762622.003.0004
Floating Signifiers and the Scientific Study of Experiences
Taves, A. (2024) · Oxford University Press eBooks · doi:10.1093/oxfordhb/9780192844064.013.21
Near-Death in the Borderlands of Consciousness
Nelson, K. R. (2024) · Oxford University Press eBooks · doi:10.1093/oxfordhb/9780192844064.013.28
Ferreira, A. S. M., Martindale, S., & Luke, D. P. (2024) · Journal of Psychedelic Studies · doi:10.1556/2054.2024.00368
Public Health and the Harm Reduction Approach to Illegal Psychoactive Substances
Emerson, B., & Haden, M. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-99967-0.00380-x
Mattu, J., & Sullivan, J. A. (2024) · Oxford University Press eBooks · doi:10.1093/oso/9780192898371.003.0007
Freizeitgebrauch von LSD und Psilocybin-Pilzen
Prepeliczay, S. (2024) · Springer eBooks · doi:10.1007/978-3-658-43431-1_44
Happiness and the Psychology of Enlightenment - An Investigation into Methods and Results
Jones, P. M. (2024) · IntechOpen eBooks · doi:10.5772/intechopen.1003515
Tewfik, G., Adaralegbe, A., Gomez, S., Aziz, R., Chaudhry, F. A., Rodriguez-Correa, D. T., & Adaralegbe, D. O. (2024) · Trends in Anaesthesia and Critical Care · doi:10.1016/j.tacc.2024.101514
Microdosing Psychedelics as a Promising New Pharmacotherapeutic
Kuypers, K. P. C. (2024) · Springer eBooks · doi:10.1007/978-3-031-61992-2_26
Is There a Right to Psychedelic-Assisted Therapy?
Kopeikin, Z. A. (2025) · The American Journal of Bioethics · doi:10.1080/15265161.2024.2433417
Cabral-Juan, P., Estrada, M. R., & Rodríguez-Gómez, J. (2024) · Revista Puertorriqueña de Psicología · doi:10.55611/reps.3501.11
Lasch, A., Schweikert, T., Dora, E., Kolb, T., Schurig, H. L., & Walther, A. (2025) · Nervenheilkunde · doi:10.1055/a-2517-1621
O Uso Terapêutico da Psilocibina em Pacientes com Câncer Terminal: Eficácia, Eficiêcia e Bem-Estar.
CASTRO, M. D., Leal, M. C. D. M., dos Santos, A. P., & Rocha, L. M. G. (2025) · REVISTA DE CIÊNCIAS SOCIAIS APLICADAS · doi:10.59370/rbcm.v1i1.194
Humphreys, J., Lukas, L. A., Beaussant, Y., Fischer, S. M., Araujo, T. S., Spence, D., Harris, J. P., Anderson, B. T., & Grob, C. S. (2025) · Oxford University Press eBooks · doi:10.1093/med/9780197760864.003.0002
Smith, A. D. T., Jsramillo, N. B., & Cuartas, D. M. B. (2025) · Medical & Clinical Case Reports Journal · doi:10.51219/mccrj/andres-david-turizo-smith/233
Liberating the Soul: Multiple Self-States and the Mystical in the Treatment of Substance Abuse
Burton, N. (2025) · Psychoanalytic Inquiry · doi:10.1080/07351690.2025.2541549
Psychedelic agents for treatment-resistant depression
Gukasyan, N., & Griffiths, R. R. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-824067-0.00014-1
Self-citationPsychedelic experiences disrupt routine thinking — and so has the coronavirus pandemic
Shore, R. (2020) · The Conversation · doi:10.64628/aam.5chdaqhg3
Spitz, N. A. (2025) · Springer eBooks · doi:10.1007/978-3-031-57159-6_5-1
Entropy as Metaphysical Perplexity in Ibn ‘Arabī’s Sufi Thought
Lala, I. (2025) · Method & Theory in the Study of Religion · doi:10.1163/15700682-bja10163
Urban, H. B. (2025) · Springer eBooks · doi:10.1007/978-3-031-98596-6_13
Torre, J. T. L., Cheung, S. M., Kam, A., & Sackett, N. B. (2025) · Research Square · doi:10.21203/rs.3.rs-8022144/v1
Intact neurophysiological markers of death denial in long-term ayahuasca users
Dor‐Ziderman, Y., David, J., & Berkovich‐Ohana, A. (2025) · Psychopharmacology · doi:10.1007/s00213-025-06963-z
Rosal, S. P., & Faber, S. C. (2025) · Research Square · doi:10.21203/rs.3.rs-8000629/v1
Metadata
- Authors
- Griffiths, R. R., Johnson, M. W., Richards, W. A., Richards, B. D., McCann, U., & Jesse, R.
- Affiliations
- Johns Hopkins University (US)
- Corresponding author
- Griffiths, Roland R.
- Venue
- Psychopharmacology
- Published
- 2011-06-15
- Volume
- 218
- Issue
- 4
- Pages
- 649-665
- ISSN
- 0033-3158 (ISSN-L)
- 1432-2072
- PMC
- PMC3308357
- OpenAlex
- W2001101493
- Semantic Scholar
- b6a466d47ff14211f273622e5d0b584d06253237
- Cited by
- 932
- References
- 38
- Citations by year
- 2026: 59 · 2025: 97 · 2024: 115 · 2023: 110 · 2022: 107 · 2021: 94 · 2020: 64 · 2019: 65 · 2018: 48 · 2017: 51 · 2016: 40 · 2015: 18 · 2014: 23 · 2013: 18 · 2012: 14
- FWCI
- 20.03
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health
- National Institute on Drug Abuse (R01DA003889, R01DA03889)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
- Social Sciences › Psychology › Social Psychology › Paranormal Experiences and Beliefs
- Social Sciences › Health › Religion, Spirituality, and Psychology
- Keywords
- psilocybin, dose-response relationship, fear and anxiety, long-term psychological effects, psychedelic therapy
- MeSH terms
- Adult, Affect, Attitude, Dose-Response Relationship, Drug, Double-Blind Method, Female, Follow-Up Studies, Hallucinogens, Humans, Male, Middle Aged, Psilocybin, Surveys and Questionnaires, Time Factors, Cross-Over Studies, Spirituality
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
